Peer-Reviewed Articles

Moorthy, L.N., Peterson, M.G.E., Hassett, A.L., Baratelli, M., Chalom, E.C., Hashkes, P.J., Hong, S., Reiff, A, Lehman, T.J.A. Relationship between health-related quality of life and SLE activity and damage in children over time. Lupus 2009;18(7):622-9.

Hassett A.L., Maclean R., Stuart M.R., Peterson C., Buyske S., Park N., Savage S.V., Li T.T., and Seligman M.E.P. The observational evaluation of subjective well-being in patients with rheumatoid arthritis. Applied Psychology: Health & Well-Being 2009;1(1):46-61.

Marques, A., Shaw, P., Schmid, C.H., Kaplan, R.F., Hassett, A.L., Shapiro, E., Steere, A., and Wormser, G.P. Correspondence: Concerns Regarding the Methodology and Interpretation of Results in a Treatment Trial of Lyme Encephalopathy. Neurology 2009;4: 383-4.

Hassett, A.L., Radvanski, D.C., Buyske, S., Savage, S.V., Gara, M., Escobar, J.I., and Sigal, L.H. The role of psychiatric comorbidity in chronic Lyme disease. Arthritis Rheum 2008; 59(12):1742-49.

Sharma, R., Kostis, W.J., Wilson, A.C., Cosgrove, N.M., Hassett, A.L., Moreyra, A.E., Delnevo, C.D., and Kostis, J.B. Questionable hospital chart documentation practices by physicians.  J Gen Intern Med 2008; 23(11):1865-70.

Merkel PA, Silliman SP, Denton CP, Furst D, Khanna D, Emery P, Hsu V et al, for the CAT-192 Research Group and the Scleroderma Clinical Trials Consortium: Validity, Reliability, and Feasibility of Durometer Measurements of  Scleroderma Skin Disease in a Multicenter Treatment Trial.  Arthritis Care and Research 59(5): 699-705, 2008.

Chung L., Shapiro L., Fiorentino D., Baron M., Shanahan J., Sule S., Hsu V, et al: MQX-503, A Novel Formulation of Nitroglycerin, Improves Severity of Raynaud’s Phenomenon: A Randomized, Controlled Trial. Arthritis & Rheum 60(3):870-877, 2009.

Dalbeth N, Perez-Ruiz F, Edwards, Schlesinger N. In defense of research into the crystal induced arthropathies. (Letter). J Rheumatol 2008;35:2278-9.

Schlesinger N. Febuxostat: A viewpoint. Drugs 2008;68(13):1876.

Perez-Ruiz F, Dalbeth N, Schlesinger N. Febuxostat, a novel drug for the treatment of hyperuricemia and gout. Future Medicine 2008;3(5):421-427.

Kimel AF, Schlesinger N.  Polymyalgia Rheumatica: To unmask the real culprit. Journal of Clinical Outcomes Management (JCOM) 2009;16(3):137-145.

Schlesinger N,  Dalbeth N, Perez-Ruiz F.  Gout – what are the treatment options. Expert Opin Pharmacother 2009;10(8):1319-1328.

Thiele RG, Schlesinger N. Ultrasonography shows disappearance of monosodium urate crystal deposition on hyaline cartilage after sustained normouricemia is achieved. Rheumatol Int. DOI 10.1007/s00296-009-1002-8

Perez-Ruiz F, Dalbeth N, Urresola A, de Miguel E, Schlesinger N. Gout. Imaging of gout: findings and utility. Arthritis Res Ther. 2009 11:232

Schlesinger N, Watson DJ, Norquist JM.  Serum urate during acute gout. J Rheumatol.  2009 36(6):1287-1289.

Nair, S. K., Verma, A., Thomas, TJ., Chou, T. C., Gallo, M. A., Shirahata, A., and Thomas T. (2007) Synergistic apoptosis of MCF-7 breast cancer cells by 2-methoxyestradiol and bis (ethyl) norspermine. Cancer Lett. 250, 311-322.

Beauchemin, R., N'soukpoé-Kossi, C. N., Thomas, T.J. Thomas, T., Carpentier, R., Tajmir-Riahi, H. A. (2007) Polyamine analogues bind human serum albumin. Biomacromolecules 8, 3177-3183.

Sundaresan, N., Suresh, C. H., Thomas, T., Thomas, T. J.,and Pillai, C. K. (2008) Liquid crystalline phase behavior of high molecular weight DNA: A Comparative study of the influence of metal ions of different size, charge and binding mode. Biomacromolecules 9, 1860-1869.

Todd, B.A., Parsegian, V.A., Shirahata, A., Thomas, T.J., and Rau, D.C. (2008) Attractive forces between cation condensed DNA double helices. Biophysical J. 94, 4775-4782.

Viola, B.M., Abraham, T.E., Arathi, D.S., Sreekumar, E., Pillai, M.R., Thomas, T.J., and Pillai, C.K.S. (2008) Synthesis and characterization of novel water-soluble polyamide based on spermine and aspartic acid as a potential gene delivery vehicle. eXPRESS Polymer Letters 2, 330-338.